KevinM.FlaniganMD

PubMed

• 29 citations
  Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy.
  Anne M. Connolly, Craig M. Zaidman, Paul T. Golumbek, Mary Michaeleen Cradock, Kevin M. Flanigan, Nancy L. Kuntz, Richard S. Finkel, Craig M. McDonald, Susan T. Iannac...> ;Muscle & Nerve. 2019 Jun 1
• 37 citations
  Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.
  Robert B. Weiss, Veronica J. Vieland, Diane M. Dunn, Yuuki Kaminoh, Kevin M. Flanigan> ;Annals of Neurology. 2018 Aug 1
• 25 citations
  A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial
  Rebecca A. Crow, Kimberly A. Hart, Michael P. McDermott, Rabi Tawil, William B. Martens, Barbara E. Herr, Elaine McColl, Jennifer Wilkinson, Janbernd Kirschner, Wendy ...> ;Trials. 2018 May 10
• 8 citations
  Low-level expression of EPG5 leads to an attenuated Vici syndrome phenotype
  Megan A. Waldrop, Felecia Gumienny, Daniel R. Boue, Emily de los Reyes, Richard Shell, Robert B. Weiss, Kevin M. Flanigan> ;American Journal of Medical Genetics. Part A. 2018 May 1
• 27 citations
  Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis.
  Mehmet Emir Yalvaç, Jakkrit Amornvit, Cilwyn Braganza, Lei Chen, Syed-Rehan Hussain, Kimberly M. Shontz, Chrystal L. Montgomery, Kevin M. Flanigan, Sarah Lewis, Zarife...> ;Skeletal Muscle. 2017 Dec 14
• 9 citations
  Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene...
  Haiyan Fu, Aaron S Meadows, Ricardo J Pineda, Krista L Kunkler, Kristen V Truxal, Kim L McBride, Kevin M Flanigan, Douglas M McCarty> ;Human Gene Therapy. Clinical Development. 2017 Dec 1
• 289 citations
  Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
  Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, Richard S. Finkel, Kevin M. Flanigan, Nathalie Goemans, Peter Heydemann, Anna Kamińska, Janbernd Kirschner...> ;Lancet. 2017 Sep 23
• 6 citations
  Clinicopathologic Conference: A Newborn With Hypotonia, Cleft Palate, Micrognathia, and Bilateral Club Feet.
  Megan A. Waldrop, Daniel R. Boue, Emily Sites, Kevin M. Flanigan, Richard Shell> ;Pediatric Neurology. 2017 Sep 1
• 15 citations
  The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials
  Lindsay N. Alfano, N. Miller, K. Berry, Han Yin, Kimberly E. Rolf, Kevin M. Flanigan, Jerry R. Mendell, Linda Lowes> ;Neuromuscular Disorders. 2017 May 1
• 70 citations
  Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes
  Jerry R. Mendell, Zarife Sahenk, Samiah Al-Zaidy, Louise R. Rodino-Klapac, Linda Lowes, Lindsay N. Alfano, K. Berry, N. Miller, Mehmet Emir Yalvaç, Igor Dvorchik, Meli...> ;Molecular Therapy. 2017 Apr 5
• 13 citations
  Modeling functional decline over time in sporadic inclusion body myositis.
  Lindsay N. Alfano, Han Yin, Igor Dvorchik, Elizabeth G. Maus, Kevin M. Flanigan, Jerry R. Mendell, Linda Lowes> ;Muscle & Nerve. 2017 Apr 1
• 7 citations
  General anesthesia with a native airway for patients with mucopolysaccharidosis type III.
  Mineto Kamata, Christopher McKee, Kristen V. Truxal, Kevin M. Flanigan, Kim L. McBride, Shawn C. Aylward, Joseph D. Tobias, Marco Corridore> ;Paediatric Anaesthesia. 2017 Feb 8
• 23 citations
  Efficient skipping of single exon duplications in DMD Patient-Derived cell lines using an antisense oligonucleotide approach
  Nicolas Wein, Adeline Vulin, Andrew R. Findlay, Felecia Gumienny, Nianyuan Huang, Steve D. Wilton, Kevin M. Flanigan> ;Journal of Neuromuscular Diseases. 2017 Jan 1
• 28 citations
  Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up.
  Anne M. Connolly, Julaine Florence, Craig M. Zaidman, Paul T. Golumbek, Jerry R. Mendell, Kevin M. Flanigan, Peter I. Karachunski, John W. Day, Craig M. McDonald, Basi...> ;Muscle & Nerve. 2016 Oct 1
• 1 citations
  Recurrent Fat Embolic Strokes in a Patient With Duchenne Muscular Dystrophy With Long Bone Fractures and a Patent Foramen Ovale.
  Christopher J. Bugnitz, Linda H. Cripe, Warren D. Lo, Kevin M. Flanigan> ;Pediatric Neurology. 2016 Oct 1
• 82 citations
  EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.
  Susan Byrne, Lara Jansen, Jean Marie U-King-im, Ata Siddiqui, Hart G.W. Lidov, Istvan Bodi, Luke Smith, R. Mein, Thomas Cullup, Carlo Dionisi-Vici, Lihadh Al-Gazali, M...> ;Brain. 2016 Mar 1
• 14 citations
  Reliability and validity of active‐seated: An outcome in dystrophinopathy
  Linda Lowes, Lindsay N. Alfano, Roger Crawfis, K. Berry, Han Yin, Igor Dvorchik, Kevin M. Flanigan, Jerry R. Mendell> ;Muscle & Nerve. 2015 Sep 1
• 408 citations
  The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
  Catherine L. Bladen, David Salgado, Soledad Monges, Maria E. Foncuberta, Kyriaki Kekou, Konstantina Kosma, Hugh Dawkins, Leanne Lamont, Anna J. Roy, Teodora Chamova, V...> ;Human Mutation. 2015 Apr 1
• 33 citations
  Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45
  Andrew R. Findlay, Nicolas Wein, Yuuki Kaminoh, Laura E. Taylor, Diane M. Dunn, Jerry R. Mendell, Wendy King, Alan Pestronk, Julaine Florence, Katherine D. Mathews, Ri...> ;Annals of Neurology. 2015 Apr 1
• 53 citations
  Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy.
  Anne M. Connolly, Elizabeth C. Malkus, Jerry R. Mendell, Kevin M. Flanigan, J. Philip Miller, Jeanine Schierbecker, Catherine Siener, Paul T. Golumbek, Craig M. Zaidma...> ;Muscle & Nerve. 2015 Apr 1
• 22 citations
  204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands.
  Alessandra Ferlini, Kevin M. Flanigan, Hanns Lochmüller, Francesco Muntoni, Peter A C 't Hoen, Elizabeth M. McNally> ;Neuromuscular Disorders. 2015 Feb 1
• 4 citations
  Visual Diagnosis: Chest Pain in a Boy With Duchenne Muscular Dystrophy and Cardiomyopathy
  Philip T. Thrush, Kevin M. Flanigan, Jerry R. Mendell, Subha V. Raman, Curt J. Daniels, Hugh D. Allen> ;Pediatrics in Review. 2014 Dec 1
• 163 citations
  A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
  Jerry R. Mendell, Zarife Sahenk, Vinod Malik, A.M. Gomez, Kevin M. Flanigan, Linda Lowes, Lindsay N. Alfano, K. Berry, Eric Meadows, Sarah Lewis, Lyndsey Braun, Kim Sh...> ;Molecular Therapy. 2015 Jan 1
• 294 citations
  Ataluren treatment of patients with nonsense mutation dystrophinopathy
  Katharine Bushby, Richard S. Finkel, Brenda Wong, Richard J. Barohn, Craig Campbell, Giacomo P. Comi, Anne M. Connolly, John W. Day, Kevin M. Flanigan, Nathalie Goeman...> ;Muscle & Nerve. 2014 Oct 1
• 33 citations
  One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development
  Anne M. Connolly, Julaine Florence, Mary Michaeleen Cradock, Michelle Eagle, Kevin M. Flanigan, Craig M. McDonald, Peter I. Karachunski, Basil T. Darras, Kate Bushby, ...> ;Pediatric Neurology. 2014 Jun 1
• Join now to see all